Glimzab-MV1 Tablet is a combination of Glimepiride and Metformin, used to manage blood sugar levels in patients with type 2 diabetes.

SKU: 70704 Categories: ,


Glimzab-MV1 Tablet is a pharmaceutical product that combines two active ingredients, Glimepiride and Metformin. This tablet is commonly used to manage diabetes mellitus type 2 and helps to control blood sugar levels.

The composition of Glimzab-MV1 Tablet includes Glimepiride, a sulfonylurea antidiabetic agent, and Metformin, a biguanide antidiabetic agent. Glimepiride works by stimulating the release of insulin from the pancreas and improving the body’s response to insulin, which helps lower blood sugar levels. Metformin, on the other hand, decreases the amount of glucose produced by the liver and enhances the body’s sensitivity to insulin.

Glimzab-MV1 Tablet is primarily used for the treatment of type 2 diabetes, providing better glycemic control. It helps to lower fasting blood sugar levels and reduce HbA1c levels. It is prescribed along with a proper diet and exercise routine to achieve optimal results in diabetes management.

This medication is indicated for patients with type 2 diabetes mellitus where diet and exercise alone do not provide adequate glycemic control. It may also be used in combination with other antidiabetic medications or insulin therapy.

In conclusion, Glimzab-MV1 Tablet with the combination of Glimepiride and Metformin is an effective treatment option for individuals with type 2 diabetes. It helps to regulate blood sugar levels by stimulating insulin release and reducing glucose production. However, it is important to consult a healthcare professional before starting any medication to ensure it is suitable for your specific condition and to understand the appropriate dosage and usage guidelines.

Additional information

Weight 46.0 g
Marketed by


Dosage form




Therapeutic use